The Metrix® COVID-19 Test

The Metrix® COVID-19 Test is a testing solution designed for simplicity and efficiency. This lab-quality COVID – 19 test delivers results in 30 minutes and is ideal for a variety of settings. FDA-authorized to work with multiple sample types – saliva or nasal swab – providing flexibility and convenience.  

Metrix® stands out from traditional testing methods by offering lab-quality results at the point-of-careA molecular lab ANYWHERE and EVERYWHERE. 

Features & Benefits:

  • Rapid Molecular Test – Provides lab quality results in 30 minutes
  • Reduce Repeat Testing – No need for serial or confirmation testing*
  • Convenient – Indicated for symptomatic and asymptomatic testing and requires no maintenance or calibration, ready for testing any time
  • Minimal Hands-On Time – Can be performed in a CLIA-waived setting in a few simple steps and stored at room temperature
  • Flexible Sampling – The only test with dual-sample types (nasal swab or saliva)
  • Exceptional Support – Experienced support teams and online training modules to help streamline your implementation

*Nasal samples only.

The Metrix® Reader, tailored for point-of-care settings, represents convenience and reliability in health diagnostics. Compact and robust, it’s ideal for professional use in diverse locations, including clinics and mobile health units. Compatible with the Metrix® COVID-19 Test.

Product Available in select countries in the following territories:

USA - Not available in all countries. Contact us for availability.

Sample Type

Saliva or Nasal Swab

Product Training

Ordering Information

Name Size Part Package Insert
Metrix® COVID-19 Test 25 tests per kit MTRX-C19-25PK Download
Metrix® Gen 2 Reader 1 reader MTRX-RDR-Gen2 N/A
Metrix® COVID-19 Molecular Test Bundle 50 tests + 1 reader MTRX-C19-B1 N/A

This product has not been FDA cleared or approved, but has been authorized for emergency use by FDA under an EUA; This product has been authorized only for the detection of nucleic acid from SARS-CoV-2, not for any other viruses or pathogens. The emergency use of this product is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostics for detection and/or diagnosis of COVID-19 under Section 564(b) (1) of the Federal Food, Drug, and Cosmetic Act, 21 U.S.C. § 360bbb 3(b)(1), unless the declaration is terminated or authorization is revoked sooner.

Get in Touch

When you’re ready to order, we’re here to help.

Fill out the form below and someone from our team will get back to you shortly.